This outcome is more common with severe structural issues, very long-standing chronic pain, or conditions better addressed by other interventions
Among these agents, semaglutide and liraglutide have consistently shown the strongest cardiovascular benefit, with semaglutide showing additional promise in patients with obesity and HFpEF
And with glutathione IV therapy, you dont need to worry if youre getting what you need from your diet to produce glutathione in adequate amounts
GLP-1s in Breast Cancer: Overall Survival, Recurrence Risk, and Safety Sherry Shen, MD Sherry Shen, MD, shares retrospective data on how GLP-1s influence overall survival and safety outcomes among patients with breast cancer
The proportion of muscle loss relative to fat loss depends on several factors, including the rate of weight loss, protein intake, physical activity levels, and the individual's starting body composition
If youre currently taking insulin or sulfonylureas, your provider will need to adjust those doses when starting tirzepatide to prevent hypoglycemia, as tirzepatide significantly improves insulin sensitivity and reduces fasting blood glucose